Compositions and methods for treating and inhibiting viral infections

A technology of virus infection and composition, applied in the field of composition for treating and inhibiting the replication of human papillomavirus, which can solve problems such as unresolved treatment and wart regeneration

Inactive Publication Date: 2015-06-10
GRACELAND BIOTECH +1
View PDF1 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Others use drugs that adjust the immune response to the virus in order to treat the warts, but these usually take more time to fight the virus and end the warts, which don't always appear
Also, while these methods can be used to target and treat existing warts, they do not necessarily treat the underlying virus, which can cause the wart to regrow, since warts are a manifestation of a viral infection

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compositions and methods for treating and inhibiting viral infections
  • Compositions and methods for treating and inhibiting viral infections
  • Compositions and methods for treating and inhibiting viral infections

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0067] A teenage male, specifically a 12-year-old Hispanic boy, observed warts on three of the five fingers of the right hand. These warts were first sanded in the manner described above for better contact with the drug, and then treated with a composition in gel form containing hydroxychloroquine as the sole active ingredient (prepared in the manner described above for this composition). This gel composition was applied to each wart in an amount approximately equal to the surface area of ​​each wart once or twice daily for about a week, after which it was observed that all warts had completely disappeared without leaving any visible scars .

Embodiment 2

[0069] Another underage male, specifically a 15 year old boy who was still Hispanic, presented with warts on his fingers. Applying the same composition as in Example 1, in the same manner and with the same frequency as in Example 1, and after about a week of this treatment, similar results were observed; that is, all warts had completely disappeared, with no Leave any visible scars.

Embodiment 3

[0071] An adult male, specifically a 55 year old Hispanic man, was observed to have genital warts, specifically, warts scattered on the skin of the scrotum. The same composition as Example 1 was applied, in the same manner and with the same frequency as in Example 1, and after about one week of this treatment, 50% of the mass disappearance of the warts was observed. Thereafter, the patient was switched to treatment with a composition comprising chloroquine as the sole active ingredient in gel form (prepared in the manner of the aforementioned composition), and treated similarly with the latter composition twice a day for two days Afterwards, it was observed that the remaining 50% of the number of warts had disappeared.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

Compositions and methods for the treatment, as well as the inhibition and prevention, of an infection of the papillomavirus and the epithelial lesions, namely, the waits of the skin and mucosal surfaces, associated therewith, in a mammalian host, as well as methods of inhibiting the replication of a papillomavirus in an infected cell, are provided. The compositions comprise a therapeutically effective amount of an active ingredient comprising at least one compound selected from the group consisting of chloroquine, hydroxychloroquine, amodiaquine, or in each case, a pharmaceutically acceptable salt thereof. The methods comprise topically administering a therapeutically and/or antivirally effective amount of such a compound to a mammalian host, such as a human being, in need of such treatment, although alternatively other routes of administration may be used, including but not limited to transdermal, transmucosal, respiratory, and by injection. The compositions optionally also comprise one or more pharmaceutically acceptable non-active ingredients.

Description

technical field [0001] The present invention relates generally to methods for treating and inhibiting papillomavirus infection and removing warts of papillomavirus origin (genesis) in mammalian hosts, and in particular, to the treatment and prevention of warts associated with papillomavirus infection in mammals. Compositions and methods for genital warts and other warts and lesions of skin and mucous membrane surfaces. More specifically, the present invention relates to compositions and methods for treating and inhibiting the replication of human papillomaviruses, thereby eliminating the cause of these warts and lesions. Background technique [0002] Human papillomavirus is a virus of the papillomaviridae family that infects the epidermis of humans. This infection can lead to epithelial damage or growth, especially warts, also known as genital warts or papillomas. A number of different HPV types have been identified, which are usually transmitted by skin-to-skin contact (or...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/4706
CPCA61K31/4706A61P17/12A61P31/12A61P31/20A61P35/00
Inventor 贾斯蒂斯·E·奥比
Owner GRACELAND BIOTECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products